ADRENAL MYELOLIPOMA

Course overview

ADRENAL MYELOLIPOMAS REPRESENT BENIGN ADRENAL NEOPLASMS PRIMARILY CONSISTING OF MATURE ADIPOSE TISSUE INTERTWINED WITH MYELOID TISSUE. THEY CONSTITUTE A NOTEWORTHY PORTION, RANGING FROM 6% TO 16%, OF ADRENAL INCIDENTALOMAS, EMERGING AS THE SECOND MOST FREQUENT ETIOLOGY FOLLOWING ADRENAL ADENOMAS. THESE LESIONS CAN EXHIBIT FUNCTIONAL OR NONFUNCTIONAL CHARACTERISTICS, ADDING A LAYER OF COMPLEXITY TO THEIR CLINICAL EVALUATION AND MANAGEMENT.THIS CONTINUING EDUCATION ACTIVITY IS DESIGNED TO PROVIDE A COMPREHENSIVE REVIEW OF THE ASSESSMENT AND TREATMENT OF ADRENAL MYELOLIPOMAS. ADDITIONALLY, IT EMPHASIZES THE CRUCIAL ROLE OF THE INTERPROFESSIONAL HEALTHCARE TEAM IN RECOGNIZING AND EFFECTIVELY MANAGING PATIENTS WITH ADRENAL MYELOLIPOMAS. BY ENHANCING OUR COLLECTIVE UNDERSTANDING OF THESE LESIONS AND PROMOTING INTERDISCIPLINARY COLLABORATION, WE CAN OPTIMIZE PATIENT CARE, REFINE DIAGNOSTIC STRATEGIES, AND TAILOR TREATMENT PLANS TO INDIVIDUAL PATIENT NEEDS.